| 000 | 00882 a2200241 4500 | ||
|---|---|---|---|
| 005 | 20250517153040.0 | ||
| 264 | 0 | _c20190709 | |
| 008 | 201907s 0 0 eng d | ||
| 022 | _a1944-446X | ||
| 024 | 7 |
_a10.1186/s40880-017-0208-5 _2doi |
|
| 040 |
_aNLM _beng _cNLM |
||
| 100 | 1 | _aAltundag, Kadri | |
| 245 | 0 | 0 |
_aIncreased pathologic complete response are expected in HER2-positive and triple-negative locally advanced breast cancers. _h[electronic resource] |
| 260 |
_bChinese journal of cancer _c05 2017 |
||
| 300 |
_a44 p. _bdigital |
||
| 500 | _aPublication Type: Letter; Comment | ||
| 650 | 0 | 4 | _aAnthracyclines |
| 650 | 0 | 4 | _aHumans |
| 650 | 0 | 4 | _aTaxoids |
| 650 | 0 | 4 | _aTriple Negative Breast Neoplasms |
| 773 | 0 |
_tChinese journal of cancer _gvol. 36 _gno. 1 _gp. 44 |
|
| 856 | 4 | 0 |
_uhttps://doi.org/10.1186/s40880-017-0208-5 _zAvailable from publisher's website |
| 999 |
_c27156487 _d27156487 |
||